Showing results (1881-1890 of 1,910) with videos related to
Sort By:
Pageof 191
MMWR. Morbidity and Mortality Weekly Report|September 9, 2021
Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17 Years - United States, August 2020-August 2021David A Siegel, Hannah E Reses, Andrea J Cool, et al.Nature Communications|December 13, 2019
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.Physiological Genomics|October 22, 2015
Gene transcripts associated with muscle strength: a CHARGE meta-analysis of 7,781 personsL C Pilling, R Joehanes, T Kacprowski, et al.Journal of Medicinal Chemistry|February 14, 2015
Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screenAurélie Mallinger, Simon Crumpler, Mark Pichowicz, et al.Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|August 9, 2022
ESPRAS Survey on Continuing Education in Plastic, Reconstructive and Aesthetic Surgery in EuropeNicholas Moellhoff, Tine Arnez, Elias Athanasopoulos, et al.Nature Communications|July 30, 2020
Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.Journal of Medicinal Chemistry|March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamilyGretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.Health Technology Assessment (Winchester, England)|November 11, 2025
Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods studyJoanne Euden, Mahableshwar Albur, Rebecca Bestwick, et al.Cell|July 25, 2023
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapyGarry Dolton, Cristina Rius, Aaron Wall, et al.ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of CancerChristine M Tarby, Amy Hart, Honghe Wan, et al.Pageof 191